https://scholars.lib.ntu.edu.tw/handle/123456789/577996| Title: | Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients | Authors: | I-CHUN CHEN Hu F.-C. Lin C.-H. Huang S.-M. Chang D.-Y. Cheng A.-L. Lu Y.-S. |
Issue Date: | 2021 | Publisher: | Churchill Livingstone | Journal Volume: | 59 | Start page/Pages: | 211-220 | Source: | Breast | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85110535616&doi=10.1016%2fj.breast.2021.07.006&partnerID=40&md5=2bef2bc7ca7ee59e788d1b8af95c3ebe https://scholars.lib.ntu.edu.tw/handle/123456789/577996 |
ISSN: | 0960-9776 | DOI: | 10.1016/j.breast.2021.07.006 | metadata.dc.subject.other: | [SDGs]SDG3 |
| Appears in Collections: | 醫學院附設癌醫中心醫院(臺大癌醫) |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
